Skip to main content
Erschienen in: Rheumatology International 11/2021

28.08.2021 | COVID-19 | Observational Research Zur Zeit gratis

The impact of the COVID-19 pandemic on patients with primary Sjögren syndrome

verfasst von: Augustin Serban, Ancuta Mihai, Alina Dima, Daniel Vasile Balaban, Mariana Jinga, Ciprian Jurcut

Erschienen in: Rheumatology International | Ausgabe 11/2021

Einloggen, um Zugang zu erhalten


The aim of this study was to investigate the perspective of Romanian patients with Sjögren syndrome (SS) on various aspects of the disease during the SARS-CoV-2 outbreak, including both the impact of COVID-19 on the disease itself as well as the effects of vaccination against SARS-CoV-2 in this group of patients. The study is an online questionnaire-based survey. We received responses from 137 SS patients. Regarding the general emotional status, 33 patients (24.0%) and 47 patients (34.3%) declared to have been sadder/depressive and more agitated/anxious during the SARS-CoV2 outbreak, respectively. During the lockdown, 49 (33.7%) patients strictly and 77 patients (56.2%) did their best to respect the home isolation measures. The income was unchanged for most of the patients (94 patients, 68.6%). Regarding access to healthcare providers, 27 patients (18.7%) postponed the consultation for fear of getting SARS-CoV2. In our study group, 31 patients (22.6%) responded that they have had COVID-19. Only one patient was completely asymptomatic, while the most frequently declared symptom was weakness (84.0%). In 17 patients among the respondents (68%) the symptoms lasted for at least 2 weeks; the most frequent long-lasting symptoms were fatigue (40.0%) and weakness (36.0%). Out of all the respondents, 53 patients (41.4%) were vaccinated against SARS-CoV2 with at least one dose. After the first dose, the most prevalent side effect was pain at the site of injection (89.2%), followed by weakness (25.0%) and myalgias (21.4%). This information will be useful for developing special programs dedicated to SARS-CoV2 infection and vaccination in patients with SS and other autoimmune diseases.
Nur mit Berechtigung zugänglich
The impact of the COVID-19 pandemic on patients with primary Sjögren syndrome
verfasst von
Augustin Serban
Ancuta Mihai
Alina Dima
Daniel Vasile Balaban
Mariana Jinga
Ciprian Jurcut
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 11/2021
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X

Weitere Artikel der Ausgabe 11/2021

Rheumatology International 11/2021 Zur Ausgabe


Die aktuelle Entwicklung im Überblick: Nachrichten, Webinare, Übersichtsarbeiten.